Pharmarise Holdings Corp (2796) Stock Price & News

2796:TYO

Pharmarise Holdings Corp

¥509.00

+0.20%

(+1.00) 1D

Oct 2, 3:30:00 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 2796...

Open

¥510

High

¥510

Low

¥507

Mkt. cap

6.14B

Avg. vol.

7.92K

Volume

4.00K

P/E ratio

81.35

52-wk high

¥554

52-wk low

¥471

EPS

¥6

Shares outstanding

9.24M

No. of employees

Open

¥510

High

¥510

Low

¥507

Mkt. cap

6.14B

Avg. vol.

7.92K

Volume

4.00K

P/E ratio

81.35

52-wk high

¥554

52-wk low

¥471

EPS

¥6

Shares outstanding

9.24M

No. of employees

Related stocks

2769

Village Vanguard Co Ltd

First-Corporation Inc

¥1,068.00

-0.47%

News stories

From web sources and news partners

TradingView

1 hour ago

AI spending to drive another strong S&P 500 earnings season, Goldman Sachs says

InteractiveCrypto

3 hours ago

The S&P 500 Looks Strong. Underneath, October Looks Thin.

Forbes

4 hours ago

S&P 500 Q3 Earnings Preview: Trends Investors Need To Watch

AOL.com

5 hours ago

History Says Stocks Typically Fall After a Fed Hike Cycle Begins -- Then Gain 6.8% Within a Year. Here's My Plan.

About Pharmarise Holdings Corp

CEOToshimichi Ohno

Employees2.03K

FoundedJun 28, 1984

Headquarters-

SectorDrug

Websitepharmarise.com

All values in JPY	Nov 2025	Feb 2026	May 2026	Aug 2026
Revenue	16.85B	16.95B	18.96B	17.24B
Cost of goods sold	14.53B	14.60B	16.41B	15.01B
Cost of revenue	14.53B	14.60B	16.41B	15.01B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.08B	2.17B	-1.88B	2.17B
Operating expense	2.05B	2.20B	2.13B	2.17B
Total operating expenses	16.58B	16.80B	18.53B	17.18B
Operating income	273.00M	159.00M	422.00M	62.00M
Other non operating income	25.00M	-30.00M	-8.00M	106.00M
EBT including unusual items	236.00M	67.00M	264.00M	80.00M
EBT excluding unusual items	239.00M	64.00M	324.00M	79.00M
Income tax expense	108.00M	193.00M	137.00M	117.00M
Effective tax rate	45.76%	-	51.89%	146.25%
Other operating expenses	-	-	3.21B	-
Net income	129.00M	-124.00M	127.00M	-36.00M
Net profit margin	0.77%	-	0.67%	-0.21%
Earnings per share	-	-	-	-
Interest and investment income	3.00M	4.00M	3.00M	6.00M
Interest expense	-62.00M	-69.00M	-93.00M	-95.00M
Net interest expenses	-59.00M	-65.00M	-90.00M	-89.00M
Depreciation and amortization charges	-	-	-	-
EBITDA	656.00M	532.25M	823.25M	463.25M
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything